 |
인쇄하기
취소
|
NHI reimbursement approved for GSK's Relenza for bird flu.
The MOHW has approved the NHI reimbursement of GSK's Relenza (zanamivir) starting from March 1, for the prevention and treatment of the bird flu.
Relenza is a Neuramidase inhibiting anti-viral drug like Tamiflu, Roche's bird flu therapy and the MOHW seemed to approve it because an alternative drug to Tamiflu should be available after the clinical report in the 2005 December edition of the Ne...
Relenza is a Neuramidase inhibiting anti-viral drug like Tamiflu, Roche's bird flu therapy and the MOHW seemed to approve it because an alternative drug to Tamiflu should be available after the clinical report in the 2005 December edition of the Ne...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.